We assessed whether genetically proxied IL‐6 signaling downregulation is associated with clinical manifestations, imaging biomarkers, and pathological hallmarks of arteriolosclerotic cSVD, using atherosclerosis‐related traits as positive controls. Here, IL6 is linked to atherosclerosis.